| 1 |
Feng S, Roll GR, Rouhani FJ, et al. The future of liver transplantation[J]. Hepatology, 2024, 80(3): 674-697.
|
| 2 |
Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study[J]. Am J Transplant, 2010, 10(6): 1420-1427.
|
| 3 |
蒋文涛． 再次肝移植进展[J/OL]. 实用器官移植电子杂志，2019, 7(2): 85-86.
|
| 4 |
Takagi K, Domagala P, Porte RJ, et al. Liver retransplantation in adult recipients: analysis of a 38-year experience in the Netherlands[J]. J Hepatobiliary Pancreat Sci, 2020, 27(1)：26-33.
|
| 5 |
Yoon PD, Patel MS, Murillo Perez CF, et al. Outcomes of adult liver retransplantation: a Canadian national database analysis[J]. Can J Gastroenterol Hepatol, 2022, 2022 ：9932631.
|
| 6 |
邢皓，陶一峰，徐琳琳，等. 器官捐献时代再次肝移植单中心回顾性研究[J/OL]. 中华移植杂志：电子版，2020, 14(6): 343-348.
|
| 7 |
杨航，罗永燕，潘璐达，等. DPMAS联合PE治疗肝衰竭的临床效果观察[J]. 肝脏，2023, 28(6): 707-710.
|
| 8 |
王兴强，刘懿禾，于立新，等. 三种人工肝模式治疗慢加急性肝衰竭晚期患者疗效对比分析[J/OL]. 实用器官移植电子杂志，2020, 8(4): 270-273.
|
| 9 |
万克强，殷芳，曾波，等. 半量血浆置换联合DPMAS与联合血浆灌流加CRRT治疗肝衰竭的临床疗效研究[J]. 重庆医学，2022, 51(11): 1861-1865.
|
| 10 |
吴若林，赵红川，耿小平. 成人再次肝移植研究进展[J]. 器官移植，2024, 15(4): 563-569.
|
| 11 |
张龙，韩国勇，陈志强，等. 再次肝移植治疗慢性移植物功能衰竭4例报告及文献复习[J]. 南京医科大学学报(自然科学版), 2024, 44(2): 247-252.
|
| 12 |
孙晓叶，沈中阳. 再次肝移植术后免疫抑制剂的应用分析[J/OL]. 实用器官移植电子杂志，2019, 7(2): 95-98.
|
| 13 |
Guo X, Wu F, Guo W, et al. Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure[J]. J Int Med Res, 2020, 48(6): 300060520932053.
|
| 14 |
Beran A, Mohamed MFH, Shaear M, et al. Plasma exchange for acute and acute-on-chronic liver failure: a systematic review and meta-analysis[J]. Liver Transpl, 2024, 30(2): 127-141.
|
| 15 |
Xu W, Zhu S, Yang L, et al. Safety and efficacy of double plasma molecular adsorption system with sequential low-volume plasma exchange in intermediate-stage hepatitis B virus-related acute-on-chronic liver failure[J]. J Med Virol, 2023, 95(3): e28650.
|
| 16 |
Xiang Y, Li R, Cai J, et al. Three artificial liver models of treatment of acute-on-chronic liver failure[J]. Ther Clin Risk Manag, 2024, 20: 731-740.
|
| 17 |
Rhu J, Kwon J, Lim M, et al. Graft-recipient-weight ratio and lowered immunosuppression is important for the success of adult liver retransplantation[J]. Sci Rep, 2023, 13(1): 12778.
|
| 18 |
Levitsky J, Goldberg D, Smith AR, et al. Acute rejection increases risk of graft failure and death in recent liver transplant recipients[J]. Clin Gastroenterol Hepatol, 2017, 15(4): 584-593.e2.
|